Ganga Pharmaceuticals Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Operating Revenue	26.93	26.37	27.36	25.86	24.89	23.74
Other Revenue	-	-	-0	-	-	-
Revenue	26.93	26.37	27.36	25.86	24.89	23.74
Revenue Growth (YoY)	-1.29%	-3.60%	5.78%	3.91%	4.83%	-22.88%
Cost of Revenue	12.27	12.19	12.51	12.49	12.92	12.44
Gross Profit	14.66	14.18	14.85	13.38	11.97	11.31
Selling, General & Admin	5.5	5.92	5.91	5.21	5.12	5.15
Other Operating Expenses	9.42	9.42	8.37	8.13	6.43	5.84
Operating Expenses	15.4	15.81	14.77	13.89	12.1	11.53
Operating Income	-0.75	-1.63	0.08	-0.51	-0.13	-0.23
Interest Expense	-1.46	-1.69	-1.81	-1.87	-1.9	-2.18
Interest & Investment Income	2.48	2.48	2.39	2.98	2.59	2.53
Other Non Operating Income (Expenses)	-1.55	-0.1	-0.04	-0.07	-0.04	0.25
EBT Excluding Unusual Items	-1.27	-0.93	0.63	0.53	0.51	0.37
Gain (Loss) on Sale of Assets	1.88	1.88	-	-	-	-
Pretax Income	0.61	0.95	0.63	0.53	0.51	0.37
Income Tax Expense	-0.19	0.16	0.17	0.14	0.13	0.17
Net Income	0.8	0.79	0.47	0.39	0.38	0.2
Net Income to Common	0.8	0.79	0.47	0.39	0.38	0.2
Net Income Growth	46.39%	69.52%	18.60%	3.74%	86.16%	-89.22%
Shares Outstanding (Basic)	6	5	5	4	4	4
Shares Outstanding (Diluted)	7	7	7	4	4	4
Shares Change (YoY)	4.46%	-	62.79%	-	-	-
EPS (Basic)	0.14	0.16	0.10	0.10	0.09	0.05
EPS (Diluted)	0.11	0.12	0.07	0.10	0.09	0.05
EPS Growth	41.58%	71.43%	-27.67%	7.53%	80.00%	-89.13%
Free Cash Flow	-9.12	-6.76	-12.86	-0.55	-2.25	-1.92
Free Cash Flow Per Share	-1.25	-1.02	-1.95	-0.14	-0.56	-0.47
Gross Margin	54.43%	53.78%	54.29%	51.73%	48.10%	47.61%
Operating Margin	-2.77%	-6.17%	0.31%	-1.99%	-0.51%	-0.95%
Profit Margin	2.96%	3.00%	1.70%	1.52%	1.52%	0.86%
Free Cash Flow Margin	-33.85%	-25.63%	-47.02%	-2.11%	-9.06%	-8.10%
EBITDA	-0.27	-1.16	0.58	0.05	0.42	0.31
EBITDA Margin	-0.99%	-4.41%	2.11%	0.18%	1.69%	1.31%
D&A For EBITDA	0.48	0.47	0.49	0.56	0.55	0.54
EBIT	-0.75	-1.63	0.08	-0.51	-0.13	-0.23
EBIT Margin	-2.77%	-6.17%	0.31%	-1.99%	-0.51%	-0.95%
Effective Tax Rate	-	16.55%	26.33%	26.01%	26.00%	45.58%
Revenue as Reported	29.84	30.73	29.75	28.85	27.48	26.29
Advertising Expenses	-	0.15	0.11	0.1	0.13	0.22

Source: S&P Global Market Intelligence. Standard template. Financial Sources.